1. The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
    Monica Fedele et al, 2017, Cancers CrossRef
  2. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis
    Shi-Min Chang et al, 2017, J Cell Physiol CrossRef
  3. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Cui-Ping Tang et al, 2017, Oncol Rep CrossRef
  4. MKL1 and STAT3 activate the activity of the luciferase reporter plasmid containing the CAAP1 gene promoter
    Jun-Yan Li et al, 2019, E3S Web Conf. CrossRef
  5. Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
    Daniela A. Ferraro et al, 2019, BMC Cancer CrossRef
  6. CCL2 promotes cell migration by inducing epithelial‐mesenchymal transition in oral squamous cell carcinoma
    Zihang Ling et al, 2019, J Oral Pathol Med CrossRef
  7. TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
    Dai Shi et al, 2019, Cell Death Dis CrossRef
  8. MicroRNA‑124 suppresses cell proliferation and invasion of triple negative breast cancer cells by targeting STAT3
    Pengfei Shi et al, 2019, Mol Med Report CrossRef
  9. A comprehensive review on oncogenic miRNAs in breast cancer.
    Maryam Maryam et al, 2021, J Genet CrossRef
  10. MicroRNA Regulation of Breast Cancer Stemness
    Brock Humphries et al, 2021, IJMS CrossRef
  11. STAT3 polymorphisms in North Africa and its implication in breast cancer
    Wafa Ziadi et al, 2021, Mol Genet Genomic Med CrossRef
  12. STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-δ12,14-prostaglandin J2 in Triple Negative Breast Cancer
    Su-Jung Kim et al, 2021, J Cancer Prev CrossRef
  13. Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
    Ajay Kumar Pal et al, 2022, Pathophysiology CrossRef
  14. STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response
    Mehrdokht Sadrkhanloo et al, 2022, Pharmacological Research CrossRef
  15. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
    Grace L Wong et al, 2022, Semin Cancer Biol CrossRef
  16. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
    Ahmed Ismail et al, 2022, International Journal of Biological Macromolecules CrossRef
  17. Unraveling the Potential of CSCs-miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
    Raquel Nogueras Pérez et al, 2023, IJMS CrossRef
  18. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness
    William S. Streitfeld et al, 2023, Cancer Biology & Therapy CrossRef
  19. Clinical importance of serum miRNA levels in breast cancer patients
    Fatih Turkoglu et al, 2024, Discov Onc CrossRef